Revenue ($USD) : $2,791,041,000
R&D spend : $153,819,000.00
Employees : 15,500
Fiscal year end : 12/31/22
CEO : Liam Kelly

Teleflex specializes in critical care and surgical technologies. Its portfolio spans vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care.

It picked up where it left off last year in terms of M&A with a urology play in the form of its $650 million deal to acquire Palette Life Sciences in July. –SW